Literature DB >> 9619351

Complexities, pitfalls, and strategies for evaluating brain tumor therapies.

R S Kaplan1.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9619351     DOI： 10.1097/00001622-199805000-00001

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN： 1040-8746            Impact factor:   3.645


× No keyword cloud information.
  6 in total

Review 1.  Brain tumor clinical trials: pitfalls and promise for the future.

Authors:  M R Gilbert
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

2.  Clinical significance of thallium-201 SPECT after postoperative radiotherapy in patients with glioblastoma multiforme.

Authors:  Gyo Iida; Kazuhiko Ogawa; Shogo Ishiuchi; Itaru Chiba; Takashi Watanabe; Naofumi Katsuyama; Yoshihiko Yoshii; Sadayuki Murayama
Journal:  J Neurooncol       Date:  2010-09-02       Impact factor: 4.130

3.  Thallium-201 SPECT: the optimal prediction of response in glioma therapy.

Authors:  Maaike J Vos; Johannes Berkhof; Tjeerd J Postma; Otto S Hoekstra; Frederik Barkhof; Jan J Heimans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-29       Impact factor: 9.236

4.  201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas.

Authors:  K Kallén; I M Burtscher; S Holtås; E Ryding; I Rosén
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

Review 5.  Prospective clinical trials of brain tumor therapy: the critical role of neurosurgeons.

Authors:  Frederick F Lang; Anthony Asher
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

Review 6.  Response criteria for glioma.

Authors:  A Gregory Sorensen; Tracy T Batchelor; Patrick Y Wen; Wei-Ting Zhang; Rakesh K Jain
Journal:  Nat Clin Pract Oncol       Date:  2008-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.